{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,13]],"date-time":"2026-03-13T02:03:11Z","timestamp":1773367391740,"version":"3.50.1"},"reference-count":62,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2025,12,1]],"date-time":"2025-12-01T00:00:00Z","timestamp":1764547200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,12,1]],"date-time":"2025-12-01T00:00:00Z","timestamp":1764547200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2025,11,13]],"date-time":"2025-11-13T00:00:00Z","timestamp":1762992000000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","award":["R01 AG061708"],"award-info":[{"award-number":["R01 AG061708"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000001","name":"National Science Foundation","doi-asserted-by":"publisher","award":["NNCI-1542205"],"award-info":[{"award-number":["NNCI-1542205"]}],"id":[{"id":"10.13039\/100000001","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100007030","name":"Les Turner ALS Foundation","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100007030","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100016755","name":"International Institute for Nanotechnology, Northwestern University","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100016755","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100007059","name":"Northwestern University","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100007059","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100032645","name":"Hevolution Foundation","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100032645","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Bioorganic Chemistry"],"published-print":{"date-parts":[[2025,12]]},"DOI":"10.1016\/j.bioorg.2025.109190","type":"journal-article","created":{"date-parts":[[2025,11,2]],"date-time":"2025-11-02T22:57:43Z","timestamp":1762124263000},"page":"109190","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"special_numbering":"C","title":["Modifications of NU-9, a potent protein aggregation inhibitor. Properties and activity in a cellular model of amyotrophic lateral sclerosis"],"prefix":"10.1016","volume":"167","author":[{"given":"Mohamed F.","family":"Elmansy","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Pedro","family":"Soares","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jose Ricardo D.","family":"dos Remedios","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Raghad","family":"Nowar","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Susan G.","family":"Fox","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Anan","family":"Yu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"William L.","family":"Klein","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Richard I.","family":"Morimoto","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Richard B.","family":"Silverman","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"issue":"11","key":"10.1016\/j.bioorg.2025.109190_bb0005","doi-asserted-by":"crossref","first-page":"1617","DOI":"10.1016\/j.mayocp.2018.04.007","article-title":"Amyotrophic lateral sclerosis: an update for 2018","volume":"93","author":"Oskarsson","year":"2018","journal-title":"Mayo Clin. Proc."},{"key":"10.1016\/j.bioorg.2025.109190_bb0010","doi-asserted-by":"crossref","first-page":"104","DOI":"10.1016\/j.pneurobio.2016.05.004","article-title":"ALS: a bucket of genes, environment, metabolism and unknown ingredients","volume":"142","author":"Zufir\u00eda","year":"2016","journal-title":"Prog. Neurobiol."},{"issue":"6","key":"10.1016\/j.bioorg.2025.109190_bb0015","doi-asserted-by":"crossref","first-page":"1241","DOI":"10.1007\/s00415-016-8091-6","article-title":"Recent advances in amyotrophic lateral sclerosis","volume":"263","author":"Riva","year":"2016","journal-title":"J. Neurol."},{"issue":"5","key":"10.1016\/j.bioorg.2025.109190_bb0020","doi-asserted-by":"crossref","first-page":"771","DOI":"10.1097\/WCO.0000000000000730","article-title":"Epidemiology of amyotrophic lateral sclerosis: an update of recent literature","volume":"32","author":"Longinetti","year":"2019","journal-title":"Curr. Opin. Neurol."},{"issue":"10107","key":"10.1016\/j.bioorg.2025.109190_bb0025","doi-asserted-by":"crossref","first-page":"2084","DOI":"10.1016\/S0140-6736(17)31287-4","article-title":"Amyotrophic lateral sclerosis","volume":"390","author":"van Es","year":"2017","journal-title":"Lancet"},{"issue":"10","key":"10.1016\/j.bioorg.2025.109190_bb0030","doi-asserted-by":"crossref","first-page":"1918","DOI":"10.1111\/ene.14393","article-title":"Amyotrophic lateral sclerosis: a clinical review","volume":"27","author":"Masrori","year":"2020","journal-title":"Eur. J. Neurol."},{"issue":"2","key":"10.1016\/j.bioorg.2025.109190_bb0035","doi-asserted-by":"crossref","first-page":"733","DOI":"10.1002\/med.21528","article-title":"Riluzole and edaravone: a tale of two amyotrophic lateral sclerosis drugs","volume":"39","author":"Jaiswal","year":"2019","journal-title":"Med. Res. Rev."},{"key":"10.1016\/j.bioorg.2025.109190_bb0040","doi-asserted-by":"crossref","DOI":"10.1016\/j.arr.2022.101790","article-title":"Drug discovery and amyotrophic lateral sclerosis: emerging challenges and therapeutic opportunities","volume":"83","author":"Soares","year":"2023","journal-title":"Ageing Res. Rev."},{"issue":"6","key":"10.1016\/j.bioorg.2025.109190_bb0045","doi-asserted-by":"crossref","first-page":"549","DOI":"10.1080\/14737175.2024.2355983","article-title":"Profiling tofersen as a treatment of superoxide dismutase 1 amyotrophic lateral sclerosis","volume":"24","author":"Oliveira Santos","year":"2024","journal-title":"Expert. Rev. Neurother."},{"issue":"2","key":"10.1016\/j.bioorg.2025.109190_bb0050","doi-asserted-by":"crossref","first-page":"139","DOI":"10.1016\/j.devcel.2017.12.020","article-title":"A futile Battle? Protein quality control and the stress of aging","volume":"44","author":"Higuchi-Sanabria","year":"2018","journal-title":"Dev. Cell"},{"issue":"11","key":"10.1016\/j.bioorg.2025.109190_bb0055","doi-asserted-by":"crossref","first-page":"1367","DOI":"10.1001\/jamaneurol.2019.2044","article-title":"Lifetime risk and heritability of amyotrophic lateral sclerosis","volume":"76","author":"Ryan","year":"2019","journal-title":"JAMA Neurol."},{"key":"10.1016\/j.bioorg.2025.109190_bb0060","doi-asserted-by":"crossref","DOI":"10.1016\/j.nbd.2019.104639","article-title":"Stress granule mediated protein aggregation and underlying gene defects in the FTD-ALS spectrum","volume":"134","author":"Baradaran-Heravi","year":"2020","journal-title":"Neurobiol. Dis."},{"issue":"8","key":"10.1016\/j.bioorg.2025.109190_bb0065","doi-asserted-by":"crossref","first-page":"4826","DOI":"10.1007\/s00415-024-12485-z","article-title":"Aberrant protein aggregation in amyotrophic lateral sclerosis","volume":"271","author":"Wang","year":"2024","journal-title":"J. Neurol."},{"issue":"9","key":"10.1016\/j.bioorg.2025.109190_bb0070","doi-asserted-by":"crossref","first-page":"3620","DOI":"10.1073\/pnas.1312245111","article-title":"Intercellular propagated misfolding of wild-type cu\/Zn superoxide dismutase occurs via exosome-dependent and -independent mechanisms","volume":"111","author":"Grad","year":"2014","journal-title":"Proc. Natl. Acad. Sci. USA"},{"issue":"6","key":"10.1016\/j.bioorg.2025.109190_bb0075","doi-asserted-by":"crossref","first-page":"939","DOI":"10.1007\/s00401-018-1915-y","article-title":"Mutant superoxide dismutase aggregates from human spinal cord transmit amyotrophic lateral sclerosis","volume":"136","author":"Ekhtiari Bidhendi","year":"2018","journal-title":"Acta Neuropathol."},{"issue":"1","key":"10.1016\/j.bioorg.2025.109190_bb0080","doi-asserted-by":"crossref","first-page":"4220","DOI":"10.1038\/s41467-018-06548-9","article-title":"Patient-derived frontotemporal lobar degeneration brain extracts induce formation and spreading of TDP-43 pathology in vivo","volume":"9","author":"Porta","year":"2018","journal-title":"Nat. Commun."},{"key":"10.1016\/j.bioorg.2025.109190_bb0085","doi-asserted-by":"crossref","first-page":"262","DOI":"10.3389\/fnmol.2019.00262","article-title":"Prion-like propagation of protein misfolding and aggregation in amyotrophic lateral sclerosis","volume":"12","author":"McAlary","year":"2019","journal-title":"Front. Mol. Neurosci."},{"issue":"14","key":"10.1016\/j.bioorg.2025.109190_bb0090","doi-asserted-by":"crossref","first-page":"4489","DOI":"10.1073\/pnas.1419228112","article-title":"Structural and kinetic analysis of protein-aggregate strains in vivo using binary epitope mapping","volume":"112","author":"Bergh","year":"2015","journal-title":"Proc. Natl. Acad. Sci. USA"},{"issue":"1","key":"10.1016\/j.bioorg.2025.109190_bb0095","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1186\/s12915-020-0751-4","article-title":"Protein assembly systems in natural and synthetic biology","volume":"18","author":"Chiesa","year":"2020","journal-title":"BMC Biol."},{"issue":"5","key":"10.1016\/j.bioorg.2025.109190_bb0100","doi-asserted-by":"crossref","first-page":"523","DOI":"10.1097\/00005072-199705000-00008","article-title":"Aggregation of mutant cu\/Zn superoxide dismutase proteins in a culture model of ALS","volume":"56","author":"Durham","year":"1997","journal-title":"J. Neuropathol. Exp. Neurol."},{"issue":"13","key":"10.1016\/j.bioorg.2025.109190_bb0105","doi-asserted-by":"crossref","first-page":"5789","DOI":"10.1523\/JNEUROSCI.23-13-05789.2003","article-title":"High threshold for induction of the stress response in motor neurons is associated with failure to activate HSF1","volume":"23","author":"Batulan","year":"2003","journal-title":"J. Neurosci."},{"key":"10.1016\/j.bioorg.2025.109190_bb0110","doi-asserted-by":"crossref","first-page":"89","DOI":"10.1016\/j.neulet.2019.04.001","article-title":"The metastability of the proteome of spinal motor neurons underlies their selective vulnerability in ALS","volume":"704","author":"Yerbury","year":"2019","journal-title":"Neurosci. Lett."},{"key":"10.1016\/j.bioorg.2025.109190_bb0115","doi-asserted-by":"crossref","DOI":"10.3389\/fmolb.2024.1383453","article-title":"Protein aggregation and therapeutic strategies in SOD1- and TDP-43- linked ALS","volume":"11","author":"Tsekrekou","year":"2024","journal-title":"Front. Mol. Biosci."},{"issue":"2","key":"10.1016\/j.bioorg.2025.109190_bb0120","doi-asserted-by":"crossref","first-page":"87","DOI":"10.3109\/17482968.2010.522586","article-title":"Identification of compounds protective against G93A-SOD1 toxicity for the treatment of amyotrophic lateral sclerosis","volume":"12","author":"Benmohamed","year":"2011","journal-title":"Amyotroph. Lateral Scler."},{"issue":"2","key":"10.1016\/j.bioorg.2025.109190_bb0125","doi-asserted-by":"crossref","first-page":"1029","DOI":"10.1016\/j.bmc.2011.11.039","article-title":"Cyclohexane 1,3-diones and their inhibition of mutant SOD1-dependent protein aggregation and toxicity in PC12 cells","volume":"20","author":"Zhang","year":"2012","journal-title":"Bioorg. Med. Chem."},{"issue":"7","key":"10.1016\/j.bioorg.2025.109190_bb0130","doi-asserted-by":"crossref","first-page":"584","DOI":"10.1021\/ml3000963","article-title":"Chiral cyclohexane 1,3-diones as inhibitors of mutant SOD1-dependent protein aggregation for the treatment of ALS","volume":"3","author":"Zhang","year":"2012","journal-title":"ACS Med. Chem. Lett."},{"issue":"2","key":"10.1016\/j.bioorg.2025.109190_bb0135","doi-asserted-by":"crossref","DOI":"10.1002\/ctm2.336","article-title":"Improving mitochondria and ER stability helps eliminate upper motor neuron degeneration that occurs due to mSOD1 toxicity and TDP-43 pathology","volume":"11","author":"Gen\u00e7","year":"2021","journal-title":"Clin. Transl. Med."},{"issue":"12","key":"10.1016\/j.bioorg.2025.109190_bb0140","doi-asserted-by":"crossref","first-page":"2615","DOI":"10.1021\/jm020017n","article-title":"Molecular properties that influence the oral bioavailability of drug candidates","volume":"45","author":"Veber","year":"2002","journal-title":"J. Med. Chem."},{"issue":"3","key":"10.1016\/j.bioorg.2025.109190_bb0145","doi-asserted-by":"crossref","first-page":"1098","DOI":"10.1021\/jm901371v","article-title":"Physicochemical space for optimum oral bioavailability: contribution of human intestinal absorption and first-pass elimination","volume":"53","author":"Varma","year":"2010","journal-title":"J. Med. Chem."},{"issue":"2","key":"10.1016\/j.bioorg.2025.109190_bb0150","doi-asserted-by":"crossref","first-page":"79","DOI":"10.4155\/fmc-2018-0339","article-title":"Experimental free ligand conformations: a missing link in structure-based drug discovery","volume":"11","author":"Chiarparin","year":"2019","journal-title":"Future Med. Chem."},{"issue":"2","key":"10.1016\/j.bioorg.2025.109190_bb0155","doi-asserted-by":"crossref","first-page":"640","DOI":"10.1021\/acs.orglett.4c04473","article-title":"Synthesis of Oxabicyclo[3.2.1]octan-3-ol scaffold via burgess reagent mediated cyclodehydration of \u03b4-diols under acidic conditions","volume":"27","author":"Elmansy","year":"2025","journal-title":"Org. Lett."},{"issue":"9","key":"10.1016\/j.bioorg.2025.109190_bb0160","doi-asserted-by":"crossref","first-page":"1318","DOI":"10.1002\/cber.19540870919","article-title":"\u00dcber Triphenyl-phosphin-methylene als olefinbildende Reagenzien I","volume":"87","author":"Wittig","year":"1954","journal-title":"Mitteil. Chemische Berichte"},{"issue":"8","key":"10.1016\/j.bioorg.2025.109190_bb0165","doi-asserted-by":"crossref","first-page":"2030","DOI":"10.1021\/acs.orglett.5b00841","article-title":"The discovery of a novel route to highly substituted \u03b1-tropolones enables expedient entry to the Core of the Gukulenins","volume":"17","author":"Kats-Kagan","year":"2015","journal-title":"Org. Lett."},{"issue":"17","key":"10.1016\/j.bioorg.2025.109190_bb0170","doi-asserted-by":"crossref","first-page":"4528","DOI":"10.1016\/j.bmcl.2006.06.028","article-title":"Studies towards the conception of new selective PPARbeta\/delta ligands","volume":"16","author":"Bass\u00e9ne","year":"2006","journal-title":"Bioorg. Med. Chem. Lett."},{"key":"10.1016\/j.bioorg.2025.109190_bb0175","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1016\/j.pbiomolbio.2022.06.001","article-title":"Proteostasis impairment and ALS","volume":"174","author":"Lambert-Smith","year":"2022","journal-title":"Prog. Biophys. Mol. Biol."},{"issue":"10","key":"10.1016\/j.bioorg.2025.109190_bb0180","doi-asserted-by":"crossref","DOI":"10.15252\/embj.2020106389","article-title":"Proteostatic imbalance and protein spreading in amyotrophic lateral sclerosis","volume":"40","author":"Cicardi","year":"2021","journal-title":"EMBO J."},{"issue":"Pt 2","key":"10.1016\/j.bioorg.2025.109190_bb0185","doi-asserted-by":"crossref","first-page":"775","DOI":"10.1093\/brain\/114.2.775","article-title":"Ubiquitin-immunoreactive intraneuronal inclusions in amyotrophic lateral sclerosis. Morphology, distribution, and specificity","volume":"114","author":"Leigh","year":"1991","journal-title":"Brain"},{"issue":"2","key":"10.1016\/j.bioorg.2025.109190_bb0190","doi-asserted-by":"crossref","first-page":"394","DOI":"10.1016\/j.febslet.2008.12.031","article-title":"Phosphorylated and ubiquitinated TDP-43 pathological inclusions in ALS and FTLD-U are recapitulated in SH-SY5Y cells","volume":"583","author":"Nonaka","year":"2009","journal-title":"FEBS Lett."},{"issue":"7","key":"10.1016\/j.bioorg.2025.109190_bb0195","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0022850","article-title":"Cytoplasmic accumulation and aggregation of TDP-43 upon proteasome inhibition in cultured neurons","volume":"6","author":"van Eersel","year":"2011","journal-title":"PLoS One"},{"issue":"1","key":"10.1016\/j.bioorg.2025.109190_bb0200","doi-asserted-by":"crossref","first-page":"75","DOI":"10.1083\/jcb.200504050","article-title":"Structural properties and neuronal toxicity of amyotrophic lateral sclerosis-associated cu\/Zn superoxide dismutase 1 aggregates","volume":"171","author":"Matsumoto","year":"2005","journal-title":"J. Cell Biol."},{"key":"10.1016\/j.bioorg.2025.109190_bb0205","doi-asserted-by":"crossref","DOI":"10.1016\/j.ejps.2021.106056","article-title":"Application of in vitro PAMPA technique and in silico computational methods for blood-brain barrier permeability prediction of novel CNS drug candidates","volume":"168","author":"Radan","year":"2022","journal-title":"Eur. J. Pharm. Sci."},{"issue":"3","key":"10.1016\/j.bioorg.2025.109190_bb0210","doi-asserted-by":"crossref","first-page":"437","DOI":"10.1177\/1087057113497981","article-title":"Significance of lipid composition in a blood-brain barrier-mimetic PAMPA assay","volume":"19","author":"Campbell","year":"2014","journal-title":"J. Biomol. Screen."},{"issue":"2","key":"10.1016\/j.bioorg.2025.109190_bb0215","doi-asserted-by":"crossref","first-page":"325","DOI":"10.1517\/17425255.1.2.325","article-title":"The rise of PAMPA","volume":"1","author":"Avdeef","year":"2005","journal-title":"Expert Opin. Drug Metab. Toxicol."},{"issue":"4","key":"10.1016\/j.bioorg.2025.109190_bb0220","doi-asserted-by":"crossref","first-page":"541","DOI":"10.1602\/neurorx.2.4.541","article-title":"Medicinal chemical properties of successful central nervous system drugs","volume":"2","author":"Pajouhesh","year":"2005","journal-title":"NeuroRx"},{"issue":"20","key":"10.1016\/j.bioorg.2025.109190_bb0225","doi-asserted-by":"crossref","first-page":"5228","DOI":"10.1021\/acs.jpcb.7b02914","article-title":"Predicting a drug\u2019s membrane permeability: a computational model validated with in vitro permeability assay data","volume":"121","author":"Bennion","year":"2017","journal-title":"J. Phys. Chem. B"},{"issue":"3","key":"10.1016\/j.bioorg.2025.109190_bb0230","doi-asserted-by":"crossref","first-page":"1266","DOI":"10.1016\/j.bmc.2016.12.049","article-title":"Highly predictive and interpretable models for PAMPA permeability","volume":"25","author":"Sun","year":"2017","journal-title":"Bioorg. Med. Chem."},{"issue":"3","key":"10.1016\/j.bioorg.2025.109190_bb0235","doi-asserted-by":"crossref","first-page":"345","DOI":"10.2478\/acph-2019-0024","article-title":"Metabolic stability and its role in the discovery of new chemical entities","volume":"69","author":"S\u0142oczy\u0144ska","year":"2019","journal-title":"Acta Pharma."},{"issue":"6","key":"10.1016\/j.bioorg.2025.109190_bb0240","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0157576","article-title":"Role of human breast Cancer related protein versus P-glycoprotein as an efflux transporter for benzylpenicillin: potential importance at the blood-brain barrier","volume":"11","author":"Li","year":"2016","journal-title":"PLoS One"},{"issue":"7","key":"10.1016\/j.bioorg.2025.109190_bb0245","doi-asserted-by":"crossref","first-page":"2476","DOI":"10.1016\/j.xphs.2019.02.005","article-title":"Validation of human MDR1-MDCK and BCRP-MDCK cell lines to improve the prediction of brain penetration","volume":"108","author":"Feng","year":"2019","journal-title":"J. Pharm. Sci."},{"issue":"10","key":"10.1016\/j.bioorg.2025.109190_bb0250","doi-asserted-by":"crossref","first-page":"1653","DOI":"10.1124\/dmd.116.072017","article-title":"An automated high-throughput metabolic stability assay using an integrated high-resolution accurate mass method and automated data analysis software","volume":"44","author":"Shah","year":"2016","journal-title":"Drug Metab. Dispos."},{"issue":"2","key":"10.1016\/j.bioorg.2025.109190_bb0255","doi-asserted-by":"crossref","first-page":"433","DOI":"10.1007\/s11095-015-1800-5","article-title":"Predicting mouse liver microsomal stability with \u201cpruned\u201d machine learning models and public data","volume":"33","author":"Perryman","year":"2016","journal-title":"Pharm. Res."},{"key":"10.1016\/j.bioorg.2025.109190_bb0260","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1016\/j.phrs.2013.06.009","article-title":"P-glycoprotein (MDR1\/ABCB1) and breast cancer resistance protein (BCRP\/ABCG2) restrict brain accumulation of the JAK1\/2 inhibitor, CYT387","volume":"76","author":"Durmus","year":"2013","journal-title":"Pharmacol. Res."},{"issue":"7","key":"10.1016\/j.bioorg.2025.109190_bb0265","doi-asserted-by":"crossref","first-page":"810","DOI":"10.2174\/1871520616666151120121928","article-title":"Blood-brain barrier and breast Cancer resistance protein: a limit to the therapy of CNS Tumors and neurodegenerative diseases","volume":"16","author":"Iorio","year":"2016","journal-title":"Anti Cancer Agents Med. Chem."},{"issue":"6","key":"10.1016\/j.bioorg.2025.109190_bb0270","doi-asserted-by":"crossref","first-page":"783","DOI":"10.2131\/jts.41.783","article-title":"Mechanisms underlying the toxic effects of antimony species in human embryonic kidney cells (HEK-293) and their comparison with arsenic species","volume":"41","author":"Verdugo","year":"2016","journal-title":"J. Toxicol. Sci."},{"issue":"1","key":"10.1016\/j.bioorg.2025.109190_bb0275","doi-asserted-by":"crossref","first-page":"71","DOI":"10.1080\/03601230701735110","article-title":"Determination of cytotoxicity of nephrotoxins on murine and human kidney cell lines","volume":"43","author":"Park","year":"2008","journal-title":"J. Environ. Sci. Health B"},{"issue":"2","key":"10.1016\/j.bioorg.2025.109190_bb0280","doi-asserted-by":"crossref","first-page":"893","DOI":"10.1007\/s00204-017-2079-6","article-title":"Prediction of liver toxicity and mode of action using metabolomics in vitro in HepG2 cells","volume":"92","author":"Ramirez","year":"2018","journal-title":"Arch. Toxicol."},{"key":"10.1016\/j.bioorg.2025.109190_bb0285","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1007\/978-1-60761-688-7_1","article-title":"General review on in vitro hepatocyte models and their applications","volume":"640","author":"Guguen-Guillouzo","year":"2010","journal-title":"Methods Mol. Biol."},{"issue":"8","key":"10.1016\/j.bioorg.2025.109190_bb0290","doi-asserted-by":"crossref","first-page":"943","DOI":"10.1001\/jamainternmed.2024.1836","article-title":"Severe acute liver injury after hepatotoxic medication initiation in real-world data","volume":"184","author":"Torgersen","year":"2024","journal-title":"JAMA Intern. Med."},{"key":"10.1016\/j.bioorg.2025.109190_bb0295","doi-asserted-by":"crossref","DOI":"10.1016\/j.cbi.2023.110838","article-title":"Unveiling drug induced nephrotoxicity using novel biomarkers and cutting-edge preventive strategies","volume":"388","author":"D\u017eidi\u0107-Krivi\u0107","year":"2024","journal-title":"Chem. Biol. Interact."},{"issue":"10","key":"10.1016\/j.bioorg.2025.109190_bb0300","doi-asserted-by":"crossref","DOI":"10.1073\/pnas.2402117122","article-title":"Inhibition of amyloid beta oligomer accumulation by NU-9: a unifying mechanism for the treatment of neurodegenerative diseases","volume":"122","author":"Johnson","year":"2025","journal-title":"Proc. Natl. Acad. Sci. USA"},{"issue":"21","key":"10.1016\/j.bioorg.2025.109190_bb0305","doi-asserted-by":"crossref","first-page":"6647","DOI":"10.1016\/j.bmcl.2012.08.114","article-title":"Substituted pyrazolones require N2 hydrogen bond donating ability to protect against cytotoxicity from protein aggregation of mutant superoxide dismutase 1","volume":"22","author":"Trippier","year":"2012","journal-title":"Bioorg. Med. Chem. Lett."},{"issue":"17","key":"10.1016\/j.bioorg.2025.109190_bb0310","doi-asserted-by":"crossref","first-page":"4528","DOI":"10.1016\/j.bmcl.2006.06.028","article-title":"Studies towards the conception of new selective PPAR\u03b2\/\u03b4 ligands","volume":"16","author":"Ekambom\u00e9 Bass\u00e9ne","year":"2006","journal-title":"Bioorg. Med. Chem. Lett."}],"container-title":["Bioorganic Chemistry"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0045206825010703?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0045206825010703?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,3,12]],"date-time":"2026-03-12T14:00:48Z","timestamp":1773324048000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0045206825010703"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,12]]},"references-count":62,"alternative-id":["S0045206825010703"],"URL":"https:\/\/doi.org\/10.1016\/j.bioorg.2025.109190","relation":{},"ISSN":["0045-2068"],"issn-type":[{"value":"0045-2068","type":"print"}],"subject":[],"published":{"date-parts":[[2025,12]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Modifications of NU-9, a potent protein aggregation inhibitor. Properties and activity in a cellular model of amyotrophic lateral sclerosis","name":"articletitle","label":"Article Title"},{"value":"Bioorganic Chemistry","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.bioorg.2025.109190","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 The Authors. Published by Elsevier Inc.","name":"copyright","label":"Copyright"}],"article-number":"109190"}}